Osborne Partners Capital Management LLC Has $9.29 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Osborne Partners Capital Management LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 94,007 shares of the exchange traded fund’s stock after purchasing an additional 1,165 shares during the quarter. Osborne Partners Capital Management LLC owned approximately 0.12% of SPDR S&P Biotech ETF worth $9,288,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. HBK Sorce Advisory LLC grew its position in SPDR S&P Biotech ETF by 2.6% in the first quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after acquiring an additional 113 shares during the period. Intellectus Partners LLC boosted its stake in shares of SPDR S&P Biotech ETF by 1.0% in the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares during the last quarter. Pacific Center for Financial Services grew its position in shares of SPDR S&P Biotech ETF by 2.8% during the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after buying an additional 118 shares during the period. Kingsview Wealth Management LLC grew its position in shares of SPDR S&P Biotech ETF by 3.8% during the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock worth $332,000 after buying an additional 127 shares during the period. Finally, Denver Wealth Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after buying an additional 127 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $97.15 on Friday. The firm’s 50 day moving average price is $99.14 and its two-hundred day moving average price is $94.60. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The stock has a market cap of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.